Health Condition 1: C220- Liver cell carcinoma
Conditions
Interventions
Intervention1: Nil: Nil
Control Intervention1: Nil: Nil
Sponsors
Mohamed Rela
Eligibility
Inclusion criteria
Inclusion criteria: 1. All patients with a diagnosis of hepatocellular carcinoma on imaging 2. All patients with a suspicion of hepatocellular caricnoma based on imaging or tumour markers (elevated AFP, PIVKA) 3. Patients undergoing surgery (resection or transplant) for hepatocellular carcinoma 4. Patients undergoing palliative care modalities (chemotherapy, immunotherapy, embolisation etc) for hepatocellular carcinoma
Exclusion criteria
Exclusion criteria: 1. Age below 18 years, or above 80 years 2. patients with liver tumors other than hepatocellular carcinoma 3. Patients who refuse to enroll for the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the mutational status of HCC patients to prognosticate the tumourTimepoint: 15 days, 1,3,6 months, 1 year, 18 months, 2 years | — |
Secondary
| Measure | Time frame |
|---|---|
| To correlate and predict risk of recurrence with existing biomarkers - alpha fetoprotein and PIVKATimepoint: 15 days, 1,3,6 months, 1 year, 18 months, 2 years | — |
Countries
India
Contacts
Public ContactDr Vasanthakumar Gunasekaran
Dr. Rela Institute and Medical Centre
Outcome results
None listed